MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Gain insights into autosomal recessive spinocerebellar ataxia 12 with genetic testing. Explore early detection, family planning, and targeted treatment options.
Explore how genetic testing can predict Barrett's Esophagus progression, enhance early cancer detection, guide treatments, and inform family risk in gastroenterology.
Explore how genetic testing enhances the diagnosis and management of beta-thalassemia, focusing on HBB mutations and potential treatment strategies.
Explore how genetic testing helps diagnose bleeding diathesis caused by thromboxane synthesis deficiency, offering insights for personalized treatments and family screening.
Explore how genetic testing for BOCFS4 helps detect breast, ovarian, and prostate cancer risks via BRCA mutations, empowering informed health decisions.
Uncover how genetic testing aids in early diagnosis and care of Brittle Cornea Syndrome 2. Learn about personalized treatment, family planning, and prevention strategies.
Genetic testing identifies TECRL mutations in CPVT3, aiding diagnosis, family screening, and personalized treatment, improving patient outcomes in cardiac disorders.
Explore how genetic testing aids in diagnosing Charcot-Marie-Tooth disease axonal type 2O. Understand its role in early detection, personalized treatments, and family planning.